Skip to main content

This job has expired

You will need to login before you can apply for a job.

Director, HEOR - Oncology

Employer
Regeneron Pharmaceuticals, Inc.
Location
Tarrytown, NY, United States
Start date
Sep 5, 2019

Job Details

Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, high LDL-cholesterol, atopic dermatitis and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including rheumatoid arthritis, asthma, pain, cancer and infectious diseases.

Summary:

The Director will formulate HEOR strategies, plans and studies and ensure their implementation on behalf of the HEOR Functional Head.

Job Responsibilities:
  • Develop and execute global and regional HEOR strategies and programs for Regeneron products, with aim to inform and support commercialization activities, including clinical development, marketing, and market access.
  • Collaborate with business partners to develop and support compelling product value propositions with aim to optimize patient access to Regeneron therapies.
  • Identify HEOR evidence requirements and gaps, and design, conduct, and deliver studies and tools to support relative value demonstration and product differentiation (e.g. prospective and retrospective observational studies, real world data analyses, cost effectiveness and budget impact models).
  • Conduct epidemiology and pharmacoepidemiology analyses and studies in support of commercialization goals (e.g. prevalence and incidence of disease, natural history of disease, prescribing and treatment patterns, comparative effectiveness).
  • Develop and implement Clinical Outcomes Assessment (COA) measurement strategies and plans in support of product labeling, patient access and product differentiation. Develop and validate COA endpoints for integration in clinical studies; analyze and communicate data from clinical trials. Produce COA evidence dossiers for regulatory submissions (e.g. FDA, EMA). Interact as necessary with Agencies on those matters.
  • Evaluate relevant health technology assessment (HTA) decisions and apply key learnings to pipeline and marketed products. Develop submissions to various HTA agencies to secure reimbursement.
  • Lead, build and execute research partnerships with key global and US national and regional health care industry organizations, including managed care, PBMs, pharmacy, IDNs, medical groups, and health care policy think-tanks/opinion leaders.
  • Maintain an up-to-date awareness of regulatory (e.g. FDA) and HTA considerations that may impact planning for and implementation of HEOR programs.
  • Identify and maintain successful research relationships with HEOR key opinion leaders and thought leaders.
  • Report, publish and disseminate HEOR data and study results in compliance with company, industry and regulatory requirements.
  • Deliver HEOR presentations to customers to support reimbursement decisions across the portfolio.
  • Collaborate with Alliance partners on HEOR plans, studies and deliverables; build and maintain constructive and productive relationships across Alliance.


Job Requirements:
  • Advanced graduate degree (Ph.D., MS, or MD, PharmD., B.Pharm with Master's degree) in HEOR-related field (e.g. pharmacoepidemiology, epidemiology, healthcare/data analytics, health economics, health services research, public health);
  • 5+ years pharma or consulting experience; at least 2 years of consulting experience is a plus;
  • Strong technical expertise required in design and conduct of HEOR studies and models in support of oncology therapeutic area;
  • Strong knowledge of regulatory (e.g. FDA) and HTA considerations in the evaluation of patient-reported outcomes in oncology clinical trials;
  • Experience in design and implementation of patient-reported data in oncology clinical trials, including experience in analysis and reporting of data;
  • Strong publication track record in HEOR/COA area with focus in oncology;
  • Excellent written and verbal communication skills required;
  • Ability to interact with and present to Senior Management.
This is an opportunity to join our select team that is already leading the way in the Pharmaceutical/Biotech industry. Apply today and learn more about Regeneron's unwavering commitment to combining good science & good business.

To all agencies: Please, no phone calls or emails to any employee of Regeneron about this opening. All resumes submitted by search firms/employment agencies to any employee at Regeneron via-email, the internet or in any form and/or method will be deemed the sole property of Regeneron, unless such search firms/employment agencies were engaged by Regeneron for this position and a valid agreement with Regeneron is in place. In the event a candidate who was submitted outside of the Regeneron agency engagement process is hired, no fee or payment of any kind will be paid.

Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, sexual orientation, gender identity, disability status, protected veteran status, or any other characteristic protected by law.

Company

Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases.
 
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune® which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.

Stock Symbol: REGN

Stock Exchange: NASDAQ

FacebookTwitterInstagramYouTube Logo

Company info
Website
Phone
914-847-7000
Location
Corporate Headquarters
777 Old Saw Mill River Road
Tarrytown
New York
10591
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert